Acadia Healthcare (NASDAQ:ACHC) Stock Price Up 6.3% – Time to Buy?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price rose 6.3% during mid-day trading on Wednesday . The company traded as high as $39.53 and last traded at $39.44. Approximately 944,052 shares changed hands during mid-day trading, a decline of 6% from the average daily volume of 1,006,032 shares. The stock had previously closed at $37.09.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on ACHC shares. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft increased their target price on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Royal Bank of Canada lowered their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research note on Monday. Barclays lowered their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and an average target price of $83.33.

Acadia Healthcare Price Performance

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a 50-day moving average of $56.48 and a 200-day moving average of $65.14. The firm has a market capitalization of $3.63 billion, a price-to-earnings ratio of 12.16, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s revenue was up 8.7% on a year-over-year basis. During the same period last year, the company earned $0.91 earnings per share. As a group, research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of ACHC. Harbor Capital Advisors Inc. purchased a new position in Acadia Healthcare in the second quarter worth $800,000. TCW Group Inc. grew its stake in shares of Acadia Healthcare by 63.8% during the second quarter. TCW Group Inc. now owns 62,888 shares of the company’s stock worth $4,247,000 after purchasing an additional 24,487 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Acadia Healthcare by 435.6% during the second quarter. SG Americas Securities LLC now owns 18,227 shares of the company’s stock worth $1,231,000 after acquiring an additional 14,824 shares during the last quarter. Principal Financial Group Inc. increased its position in Acadia Healthcare by 19.4% during the 2nd quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock worth $43,463,000 after purchasing an additional 104,359 shares during the period. Finally, Texas Permanent School Fund Corp boosted its position in Acadia Healthcare by 11.3% during the second quarter. Texas Permanent School Fund Corp now owns 89,821 shares of the company’s stock worth $6,067,000 after purchasing an additional 9,115 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.